-
Osobe Vidi sve
Ovjeren akaunt@Catapult_UK Catapults are a rapidly growing network of
#technology centres, established by@innovateuk with over £1bn of UK government#funding &#innovation#investment. -
4 hacks that allow you to push patient safety during cell and gene therapies to the next level. Check out our http://CGT.STREAM – our logistical solution for a successful CAR-T cell therapy! _________ https://ecs.page.link/MjDF9
#celltherapy#genetherapypic.twitter.com/r7UAULYvtU
-
On
#WorldCancerDay
the @WHO issued this report (https://bit.ly/2vb3Cs7 ). Prevention and management are key - especially for rarer#cancer indications such as#sarcoma. Our teams work hard to discover and develop new#celltherapy treatments. -
Synthetic biology can be used to engineer more sophisticated future cell and gene therapies.
@SentiBio CEO@timlu talks about their work to program and functionally enhance “living medicines.”#synbio#celltherapy#genetherapyhttps://www.genengnews.com/insights/gene-circuits-empower-next-generation-cell-and-gene-therapies/ … -
Take a look at our insights covering the novel treatment approaches and advancements in CAR-T cell therapies. https://hubs.ly/H0mTTJ20
#CAR-T#CellTherapy#MaxValpic.twitter.com/mXwmezYolH
-
PACT Pharma strives to expand their manufacturing operations of
#CellTherapy products, raising $75 million in their Series C financing round. Read about how they plan to develop new cell therapies that target solid tumors ==>http://bit.ly/PACTCellTher#biotech#healthcarepic.twitter.com/XFSU9h0YnT
-
Nice, short summary of 3 keys in selecting a CDMO.
#Pharma#Biotech#CellTherapy#CDMOhttps://lnkd.in/e4YPz8u -
[Infographic] We can’t believe that the first month of 2020 is already over! Reflecting back, 2019 was a great year for RoslinCT. Looking ahead, 2020 is already gearing up to be even better!
#yearinreview#infographic#celltherapy#genetherapy#atmppic.twitter.com/JFvCUMYnkq
-
Tmunity is committed to our relentless pursuit of restoring hope for cancer patients worldwide
#WorldCancerDay2020
#Tmunitytx#CellTherapy -
Researchers have developed a new way to “switch off” the CAR T-cell therapy when a cancer patient’s life is in danger, paving the way for safer
#immunotherapy approaches to target solid tumors. http://bit.ly/2ShBV95#celltherapy -
With $315M
@MaSTherCell acquisition,@CatalentPharma eyes growth in#celltherapy development, manufacturing: http://ow.ly/XVk750ydnPz pic.twitter.com/AlNtJvYwWt
-
All set up and ready for the next couple of days at the cell and gene therapy innovation meeting in Berlin
#CellTherapy#viralvectors @biotechnepic.twitter.com/yU9jG2OOHj
-
These talks have been broken up into bite-sized pieces - if you have 15-30 minutes, you can watch one of these webinars from our wonderful supply chain and logistics speakers!
#CellTherapy#GeneTherapyhttps://twitter.com/CCRM_ca/status/1224771407936217090 …
-
“Undetected chemicals cold leaks.” “Protected practicals hold peaks.”
@ArmyERDC#cold#leaks#celltherapy pic.twitter.com/umBm3l5eMB
-
Rewinding to a great news story on
#WorldCancerDay
- Sophie, the first person in the Midlands to receive advanced CAR-T #celltherapy, is now in complete remission from leukaemia as a result of this advanced treatment > https://www.birminghamhealthpartners.co.uk/car-t-success-for-uhb-patient/ …pic.twitter.com/f9tbZxWT3T
-
Mesenchymal stromal/stem cell (
#MSC) genomic integrity: New digital PCR test from#stemgenomics#stemcell#celltherapy#regenerativemedicine https://stemgenomics.com/mesenchymal-stromalstem-cell-msc-genomic-integrity-new-digital-pcr-test …pic.twitter.com/DxaBDYDU24
-
#CellTherapy Worrying doesn’t change your situation focus your energy on the outcome you want then do what you can to make it happen.. I Am S.C. Yatta Follow me on Facebook Instagram and Twitter @ S.C. Yatta -
Orgenesis sells Masthercell Global, its contract development and manufacturing organisation subsidiary. Will use $127 million to continue to grow its point-of-care
#celltherapy business and to further the development of its#ATMPs. https://tinyurl.com/whfbu7u -
Register for our exclusive Bioanalysis Zone Coffee Chat focusing on developments in cell and gene therapies featuring Frontage's expert, Weiping Shao!
#CellTherapy#GeneTherapy Register, here: http://bit.ly/2Uw5nLt pic.twitter.com/Y3s6HZ8lyD
-
Lineage is developing a novel
#celltherapy to treat dry age-related macular degeneration (#AMD), the leading cause of irreversible vision loss in the US. OpRegen is currently in Phase I/IIa and has the potential to help many patients. https://investor.lineagecell.com/news-releases/news-release-details/lineage-provides-update-patient-enrollment-phase-iiia-clinical …pic.twitter.com/hxZ6YjG9v3
-
Love the fresh clod weather and view..
#Switzerland#Photos#CellTherapy pic.twitter.com/Yg9Yb18Hz9
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.